New technologies for making vaccines (Q33589117)

28 July 2017

1 reference

title

New technologies for making vaccines (English)

1 reference

28 July 2017

Ellis RW

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

issue

13-14

1 reference

28 July 2017

page(s)

1596-1604

1 reference

History of Sabin attenuated poliovirus oral live vaccine strains

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Development and characterization of cold-adapted viruses for use as live virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Immunogenicity and pathogenicity of temperature-sensitive modified respiratory syncytial virus in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

A discussion on technologies for rural health. Smallpox eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Alphaviruses--vectors for the expression of heterologous genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Inactivated poliovirus vaccine: past and present experience

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

The acellular pertussis vaccine trials: an interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Insulin prophylaxis in individuals at high risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Polyvalent recombinant antigens: a new vaccine strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Phase I Clinical Trial of a Recombinant Malaria Vaccine Consisting of the Circumsporozoite Repeat Region of Plasmodium Falciparum Coupled to Hepatitis B Surface Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Modulation of cancer patients' immune responses by administration of anti-idiotypic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Gene transfer with a series of lipophilic DNA-binding molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV-infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900416-2

7 January 2021

10.1016/S0264-410X(98)00416-2

Identifiers

DOI

1 reference

28 July 2017

1 reference